ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Psychiatry

Top Psychiatry Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS HAYS MD

Psychiatry

16,647

$2.19M

728
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$132
Average prescription price

Avg: $124

STEVEN FOGELMAN M.D.

Psychiatry

13,610

$1.67M

633
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $124

MARK SLAVEN MD

Psychiatry

12,729

$1.14M

581
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $124

VALENTIN BRAGIN M.D.

Psychiatry

11,956

$1.35M

539
529 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $124

KISHOR ZINZUVADIA M.D.

Psychiatry

10,554

$1.69M

531
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $124

MARC TARLE M.D.

Psychiatry

10,176

$1.23M

726
366 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $124

HORACIO CAPOTE M.D.

Psychiatry

10,016

$2.32M

738
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 25%

$232
Average prescription price

Avg: $124

DAVID MOLINA M.D.

Psychiatry

9,259

$1.27M

403
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $124

SAMPATH NEERUKONDA M.D.

Psychiatry

8,865

$1.23M

511
209 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $124

JIHYUK HAN M.D.

Psychiatry

8,331

$1.4M

371
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$168
Average prescription price

Avg: $124

JOHN NAPOLI PHD

Psychiatry

7,867

$1.19M

544
87 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$152
Average prescription price

Avg: $124

LEONID IZRAYELIT MD

Psychiatry

7,734

$937K

461
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $124

JAWEED HUSAIN M.D.

Psychiatry

7,723

$1.06M

340
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $124

ARKADY LEVITAN M.D.

Psychiatry

7,459

$736K

513
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $124

GIOVANNY NUNEZ M.D.

Psychiatry

7,333

$811K

424
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $124

BRIJ SARAN MD

Psychiatry

7,324

$872K

340
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 25%

$119
Average prescription price

Avg: $124

INNA YURYEV-GOLGER MD

Psychiatry

7,255

$616K

397
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $124

VIKHTA GUREVICH M.D.

Psychiatry

7,191

$790K

372
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 25%

$110
Average prescription price

Avg: $124

ALEXANDER PINKUSOVICH MD

Psychiatry

7,116

$1.22M

501
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 25%

$171
Average prescription price

Avg: $124

ZINAIDA LYUBOFF MD

Psychiatry

7,112

$754K

351
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $124

JEFFERY GRACE M.D.

Psychiatry

7,083

$843K

263
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 25%

$119
Average prescription price

Avg: $124

NAMBI SALGUNAN MD

Psychiatry

7,060

$876K

258
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $124

MIKHAIL PRESMAN MD

Psychiatry

6,999

$621K

439
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 25%

$89
Average prescription price

Avg: $124

GINA PEREZ M.D.

Psychiatry

6,810

$843K

275
58 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $124

KUSUM KATHPALIA M.D.

Psychiatry

6,665

$1.02M

314
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 25%

$154
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank